Supplemental material
Open access
604
Views
0
CrossRef citations to date
0
Altmetric
Articles/Brief Reports
Persistent pain and its predictors after starting anti-tumour necrosis factor therapy in psoriatic arthritis: what is the role of inflammation control?
C Roseman1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden
https://orcid.org/0000-0003-0567-0874View further author information
JK Wallman1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden
https://orcid.org/0000-0002-4915-2924View further author information
A Jöud2 Department of Laboratory Medicine, Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden
https://orcid.org/0000-0001-7192-4911View further author information
MEC Schelin3 Department of Clinical Sciences Lund, Oncology, Lund University, Lund, Sweden;4 Department of Research and Development, Skåne University Hospital, Lund, Sweden;5 The Institute for Palliative Care, Lund University and Region Skåne, Lund, Sweden
https://orcid.org/0000-0001-5486-7556View further author information
JT Einarsson1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden
https://orcid.org/0000-0003-3206-7050View further author information
E Lindqvist1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden
https://orcid.org/0000-0002-9937-6352View further author information
J Lampa6 Karolinska Institute, Department of Medicine Solna, Rheumatology Unit, Center of Molecular Medicine (CMM), Stockholm, Sweden
https://orcid.org/0000-0002-7856-3968View further author information
MC Kapetanovic1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden
https://orcid.org/0000-0002-7853-514XView further author information
T Olofsson1 Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden;3 Department of Clinical Sciences Lund, Oncology, Lund University, Lund, SwedenCorrespondence[email protected]
https://orcid.org/0000-0002-9919-4487View further author information
Pages 94-103
|
Received 16 Feb 2023, Accepted 11 Sep 2023, Published online: 30 Nov 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.